CAFE Comparison of Atypicals in First Episode of Psychosis
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the
currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine
(100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia,
schizophreniform disorder, or schizoaffective disorder who are experiencing their first
psychotic episode.